Who We Are
A committed partner in animal health
Since 1991, MCI Santé Animale has been developing and manufacturing high-quality veterinary vaccines and pharmaceutical products trusted across more than 25 countries. Supported by a team of over 190 scientists, veterinarians, and industry professionals, MCI serves animal health authorities, distributors, and veterinary practitioners worldwide, with more than 258 active marketing authorisations.
MCI is headquartered in Mohammedia, Morocco, strategically positioned near Casablanca, with direct access to the country's largest seaport and international airport, facilitating its growing international operations and distribution network.
Our Vision
To be a leading regional animal health company, delivering innovative veterinary solutions that advance animal health and welfare, support sustainable livestock production, enhance companion animal care, and contribute to healthier communities.
Our Mission
To develop, manufacture, and distribute high-quality veterinary vaccines, pharmaceuticals, and animal health solutions for livestock and companion animals, improving animal health and welfare while expanding access to quality veterinary products across the regions we serve.
35+
Years of Excellence
190+
Dedicated Professionals
25+
Countries Served
GMP-Certified Facility
Manufacturing capabilities meeting international quality standards
MCI Santé Animale operates a state-of-the-art manufacturing facility designed and managed in accordance with the highest international quality and biosafety standards.
Our production facility is GMP-certified by nine regulatory authorities and regions worldwide, including European GMP certification. All vaccines and pharmaceutical products are manufactured under rigorous quality systems, ensuring safety, efficacy, consistency, and compliance with internationally recognised regulatory requirements.
The facility integrates advanced production, quality control, and research infrastructure, including BSL-3 virology and bacteriology laboratories, ABSL-3 animal premises for safety and efficacy testing, and a dedicated vaccine pilot formulation unit.
MCI's manufacturing platform encompasses a broad range of biological technologies, including cell culture, bioreactor production, embryonated egg technology, bacterial fermentation, and freeze-drying processes. These capabilities enable the development and production of high-quality vaccines for major livestock diseases, supporting sustainable animal health programmes.
By 2027, a new production unit currently under qualification will lift total annual capacity to 800 million live attenuated and 360 million inactivated doses.
Partnerships
Working with global, regional, and national animal health stakeholders
At MCI Santé Animale, partnerships are central to our mission of improving animal health and livestock productivity. We work closely with governments, international organisations, research institutions, development partners, distributors, and private-sector stakeholders to expand access to high-quality veterinary solutions and strengthen animal health systems worldwide.
By combining scientific expertise, manufacturing capabilities, and local market knowledge, we help translate innovation into practical solutions that address field needs and support sustainable livestock development.
Global and Regional Partnerships
MCI collaborates with international and regional organisations, animal health authorities, research centres, and industry partners to support disease prevention, vaccine access, capacity building, and market development initiatives.
These partnerships enable the exchange of expertise, the implementation of joint programmes, and the development of innovative solutions adapted to regional priorities and livestock production systems.
Capacity building and technology transfer
Strengthening local capabilities is a key component of MCI's partnership approach.
Through collaboration with public institutions and development partners, we provide technical training in vaccine production, quality control, biosafety, and regulatory systems. We also support technology transfer initiatives, public-private partnerships, and institutional strengthening programmes that contribute to building sustainable and resilient animal health systems.
Supporting global disease control programmes
MCI actively contributes to international efforts aimed at the prevention, control, and eventual eradication of major transboundary animal diseases.
As part of its commitment to the Global Programme for the control and eradication of Peste des Petits Ruminants (PPR), MCI supplies a PPR vaccine that is selected for the WOAH PPR Vaccine Bank and registered with FAO, supporting vaccination campaigns and disease control initiatives in affected countries.
MCI also contributes to the control of other priority livestock diseases through its sheep and goat pox and lumpy skin disease (LSD) vaccines, both of which are registered with FAO.
Africa Strategy
A long-term commitment to animal health in Africa
Africa is home to one-third of the world's livestock and accounts for approximately 40% of agricultural GDP generated by the livestock sector. Recognising both the continent's potential and the challenges facing animal health systems, MCI Santé Animale has developed a dedicated Africa Plan aimed at expanding access to high-quality vaccines and veterinary solutions.
By working with distributors, veterinary service providers, producer organisations, governments, and development partners, MCI strengthens distribution networks, enhances last-mile delivery, builds local capacity, and promotes vaccine adoption to support sustainable livestock development across the continent.
3
Liaison Offices
Kenya · Nigeria · Tanzania
12
Distributors
West, Central & East Africa
90
Marketing Authorisations
Across Sub-Saharan Africa
Advocacy & Awareness
Raising awareness on priority diseases and the economic impact of vaccination among farmers, veterinarians, and national authorities.
Capacity Building
Hands-on training programmes supporting the professionalisation of animal health services across the continent.
Access & Affordability
Distribution networks built for diverse markets, from commercial farms to small-scale traditional livestock keepers.
History
Over three decades of growth, science, and global impact
MCI Founded
MCI Santé Animale is established in Mohammedia, Morocco, specialising in the manufacturing and marketing of veterinary pharmaceutical products for livestock and companion animals.
Pharmaceutical Production Launched
Our story